Inspire Medical Systems
INSP
298 hedge funds and large institutions have $6.52B invested in Inspire Medical Systems in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 101 increasing their positions, 100 reducing their positions, and 34 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
38% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 34
17% more call options, than puts
Call options by funds: $99.2M | Put options by funds: $84.7M
10% more capital invested
Capital invested by funds: $5.94B → $6.52B (+$581M)
3% more funds holding
Funds holding: 288 → 298 (+10)
3.36% more ownership
Funds ownership: 94.49% → 97.85% (+3.4%)
1% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 100
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$126M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$71M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$67.7M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$64.8M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$60.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$57.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$45.1M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$30.8M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$29.7M |
INSP Hedge Fund Activity: Q1 2022 in Review
298 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2022, worth a combined $6.52B — up 9.8% from $5.94B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new INSP positions and 34 closed out — a net gain of 13 holders — while 101 added to existing stakes and 100 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $126M. The largest seller was Credit Suisse, cutting an estimated $60.8M.
- 298 institutional investors held Inspire Medical Systems (INSP) as of Q1 2022, up from 288 in Q4 2021.
- Funds reported $6.52B of Inspire Medical Systems stock for Q1 2022, up 9.8% quarter-over-quarter.
- 47 funds opened new Inspire Medical Systems positions in Q1 2022 and 34 closed out, a net change of +13 holders.
- The largest Inspire Medical Systems buyer in Q1 2022 was Fidelity Investments, an estimated $126M added.
- The largest Inspire Medical Systems seller in Q1 2022 was Credit Suisse, an estimated $60.8M sold.
Based on aggregated 13F filings for Q1 2022.